WHO ICTRP trial
A study to evaluate the safety and efficacy of ARGX-113 in patients with Mild to…
EUCTR2017-002333-40-HU · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2017-002333-40-HU |
|---|---|
| Public title | A study to evaluate the safety and efficacy of ARGX-113 in patients with Mild to Moderate Pemphigus (Vulgaris or Foliaceus) |
| Scientific title | An Open-label, Non-controlled, Phase II Study to Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, Efficacy and Conditions of Use of ARGX-113 in Patients with Mild to Moderate Pemphigus (Vulgaris or Foliaceus) |
| Primary sponsor | argenx BVBA |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Hungary;Ukraine;Romania;Israel;Germany;Italy |
| Conditions | Pemphigus (Vulgaris or Foliaceus) MedDRA version: 20.0 Level: LLT Classification code 10052802 Term: Pemphigus vulgaris System Organ Class: 100000004858 MedDRA version: 20.0 Level: LLT Classification code 10057069 Term: Pemphigus foliaceus… |
| Interventions | Product Name: ARGX-113 Product Code: ARGX-113 Pharmaceutical Form: Solution for infusion INN or Proposed INN: efgartigimod CAS Number: 1821402-21-4 Current Sponsor code: ARGX-113 Concentration unit: mg/kg milligram(s)/kilogram Concentration… |
| Registration date | Jul 20, 2017 |
| Target size | 12 |
| Secondary IDs | ARGX-113-1701;2017-002333-40-DE |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: